Loading...

Meilleure Health International Industry Group

SEHK:2327
Snowflake Description

Excellent balance sheet with acceptable track record.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
2327
SEHK
HK$3B
Market Cap
  1. Home
  2. HK
  3. Capital Goods
Company description

Meilleure Health International Industry Group Limited, an investment holding company, primarily provides anti-aging health management services in Hong Kong and Mainland China. The last earnings update was 91 days ago. More info.


Add to Portfolio Compare Print
  • Meilleure Health International Industry Group has significant price volatility in the past 3 months.
2327 Share Price and Events
7 Day Returns
-6.2%
SEHK:2327
1.6%
HK Trade Distributors
1%
HK Market
1 Year Returns
40.2%
SEHK:2327
1.1%
HK Trade Distributors
-4.7%
HK Market
2327 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Meilleure Health International Industry Group (2327) -6.2% -4.7% -45.5% 40.2% 82.1% 71.8%
HK Trade Distributors 1.6% 2.6% -7.3% 1.1% -24.1% -52.9%
HK Market 1% 3.9% -7.8% -4.7% 17.5% 2%
1 Year Return vs Industry and Market
  • 2327 outperformed the Trade Distributors industry which returned 1.1% over the past year.
  • 2327 outperformed the Market in Hong Kong which returned -4.7% over the past year.
Price Volatility
2327
Industry
5yr Volatility vs Market

2327 Value

 Is Meilleure Health International Industry Group undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Meilleure Health International Industry Group to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Meilleure Health International Industry Group.

SEHK:2327 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 1 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 8.5%
Perpetual Growth Rate 10-Year HK Government Bond Rate 2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for SEHK:2327
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year HK Govt Bond Rate 2%
Equity Risk Premium S&P Global 6.7%
Trade Distributors Unlevered Beta Simply Wall St/ S&P Global 0.92
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.917 (1 + (1- 25%) (8.06%))
0.982
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.98
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2% + (0.982 * 6.65%)
8.53%

Discounted Cash Flow Calculation for SEHK:2327 using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Meilleure Health International Industry Group is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

SEHK:2327 DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (HKD, Millions) Source Present Value
Discounted (@ 8.53%)
2020 2.73 Est @ 84.28% 2.51
2021 4.36 Est @ 59.6% 3.70
2022 6.20 Est @ 42.32% 4.85
2023 8.07 Est @ 30.22% 5.82
2024 9.83 Est @ 21.76% 6.53
2025 11.38 Est @ 15.83% 6.97
2026 12.71 Est @ 11.68% 7.17
2027 13.83 Est @ 8.78% 7.18
2028 14.76 Est @ 6.75% 7.07
2029 15.55 Est @ 5.32% 6.86
Present value of next 10 years cash flows HK$58.65
SEHK:2327 DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= HK$15.55 × (1 + 2%) ÷ (8.53% – 2%)
HK$242.97
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= HK$242.97 ÷ (1 + 8.53%)10
HK$107.16
SEHK:2327 Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= HK$58.65 + HK$107.16
HK$165.81
Equity Value per Share
(HKD)
= Total value / Shares Outstanding
= HK$165.81 / 4,271.75
HK$0.04
SEHK:2327 Discount to Share Price
Calculation Result
Value per share (HKD) From above. HK$0.04
Current discount Discount to share price of HK$0.61
= -1 x (HK$0.61 - HK$0.04) / HK$0.04
-1471.6%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Meilleure Health International Industry Group is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Meilleure Health International Industry Group's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Meilleure Health International Industry Group's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
SEHK:2327 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in HKD HK$0.02
SEHK:2327 Share Price ** SEHK (2019-07-18) in HKD HK$0.61
Hong Kong Trade Distributors Industry PE Ratio Median Figure of 30 Publicly-Listed Trade Distributors Companies 10.42x
Hong Kong Market PE Ratio Median Figure of 1,510 Publicly-Listed Companies 10.82x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Meilleure Health International Industry Group.

SEHK:2327 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= SEHK:2327 Share Price ÷ EPS (both in HKD)

= 0.61 ÷ 0.02

28.35x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Meilleure Health International Industry Group is overvalued based on earnings compared to the HK Trade Distributors industry average.
  • Meilleure Health International Industry Group is overvalued based on earnings compared to the Hong Kong market.
Price based on expected Growth
Does Meilleure Health International Industry Group's expected growth come at a high price?
Raw Data
SEHK:2327 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 28.35x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
-1.2%per year
Global Trade Distributors Industry PEG Ratio Median Figure of 80 Publicly-Listed Trade Distributors Companies 1.17x
Hong Kong Market PEG Ratio Median Figure of 479 Publicly-Listed Companies 0.8x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Meilleure Health International Industry Group, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Meilleure Health International Industry Group's assets?
Raw Data
SEHK:2327 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in HKD HK$0.21
SEHK:2327 Share Price * SEHK (2019-07-18) in HKD HK$0.61
Hong Kong Trade Distributors Industry PB Ratio Median Figure of 59 Publicly-Listed Trade Distributors Companies 0.79x
Hong Kong Market PB Ratio Median Figure of 2,197 Publicly-Listed Companies 0.92x
SEHK:2327 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= SEHK:2327 Share Price ÷ Book Value per Share (both in HKD)

= 0.61 ÷ 0.21

2.92x

* Primary Listing of Meilleure Health International Industry Group.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Meilleure Health International Industry Group is overvalued based on assets compared to the HK Trade Distributors industry average.
X
Value checks
We assess Meilleure Health International Industry Group's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Trade Distributors industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Trade Distributors industry average (and greater than 0)? (1 check)
  5. Meilleure Health International Industry Group has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

2327 Future Performance

 How is Meilleure Health International Industry Group expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

  • No analysts cover Meilleure Health International Industry Group, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
-1.2%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Meilleure Health International Industry Group expected to grow at an attractive rate?
  • Meilleure Health International Industry Group's earnings are expected to decrease over the next 1-3 years, this is below the low risk savings rate of 2%.
Growth vs Market Checks
  • Meilleure Health International Industry Group's earnings growth is expected to exceed the Hong Kong market average.
  • Meilleure Health International Industry Group's revenue growth is positive but not above the Hong Kong market average.
Annual Growth Rates Comparison
Raw Data
SEHK:2327 Future Growth Rates Data Sources
Data Point Source Value (per year)
SEHK:2327 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts -1.2%
SEHK:2327 Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 5.3%
Hong Kong Trade Distributors Industry Earnings Growth Rate Market Cap Weighted Average 9.7%
Asia Trade Distributors Industry Revenue Growth Rate Market Cap Weighted Average 12%
Hong Kong Market Earnings Growth Rate Market Cap Weighted Average -5.2%
Hong Kong Market Revenue Growth Rate Market Cap Weighted Average 13.5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
SEHK:2327 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in HKD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
SEHK:2327 Future Estimates Data
Date (Data in HKD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-12-31 266 1
2020-12-31 245 1
2019-12-31 224 1
SEHK:2327 Past Financials Data
Date (Data in HKD Millions) Revenue Cash Flow Net Income *
2018-12-31 231 18 81
2018-09-30 181 -38 81
2018-06-30 132 -94 81
2018-03-31 101 -79 81
2017-12-31 69 -63 80
2017-09-30 83 -177 60
2017-06-30 97 -291 40
2017-03-31 82 -276 37
2016-12-31 67 -261 34

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Meilleure Health International Industry Group's earnings are expected to decrease over the next 1-3 years, this is not considered high growth.
  • Meilleure Health International Industry Group's revenue is expected to grow by 5.3% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
SEHK:2327 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from Meilleure Health International Industry Group Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SEHK:2327 Future Estimates Data
Date (Data in HKD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-12-31
2020-12-31
2019-12-31
SEHK:2327 Past Financials Data
Date (Data in HKD Millions) EPS *
2018-12-31 0.02
2018-09-30 0.02
2018-06-30 0.02
2018-03-31 0.02
2017-12-31 0.02
2017-09-30 0.02
2017-06-30 0.01
2017-03-31 0.01
2016-12-31 0.01

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Meilleure Health International Industry Group will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Meilleure Health International Industry Group's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Hong Kong market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Asia market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Meilleure Health International Industry Group has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

2327 Past Performance

  How has Meilleure Health International Industry Group performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Meilleure Health International Industry Group's growth in the last year to its industry (Trade Distributors).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Meilleure Health International Industry Group has delivered over 20% year on year earnings growth in the past 5 years.
  • Meilleure Health International Industry Group's 1-year earnings growth is less than its 5-year average (0.6% vs 20.9%)
  • Meilleure Health International Industry Group's earnings growth has not exceeded the HK Trade Distributors industry average in the past year (0.6% vs 7.8%).
Earnings and Revenue History
Meilleure Health International Industry Group's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Meilleure Health International Industry Group Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SEHK:2327 Past Revenue, Cash Flow and Net Income Data
Date (Data in HKD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 230.54 80.54 33.19
2018-09-30 181.45 80.89 30.94
2018-06-30 132.37 81.25 28.70
2018-03-31 100.54 80.66 26.28
2017-12-31 68.71 80.07 23.86
2017-09-30 82.69 59.89 22.77
2017-06-30 96.67 39.71 21.69
2017-03-31 81.67 37.05 18.76
2016-12-31 66.66 34.38 15.83
2015-12-31 76.00 10.31 9.85
2015-09-30 16.58 -1.44 8.05
2015-06-30 12.96 0.27 7.84
2015-03-31 9.34 1.98 7.64
2014-12-31 15.74 0.76 7.72
2014-09-30 22.14 -0.45 7.80
2014-06-30 28.61 44.38 8.93
2014-03-31 35.08 89.22 10.07
2013-12-31 34.04 87.14 11.96
2013-09-30 32.99 85.05 13.86
2013-06-30 34.32 63.40 13.38
2013-03-31 35.65 41.75 12.89
2012-12-31 64.99 61.42 14.90
2012-09-30 94.32 81.09 16.91

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Meilleure Health International Industry Group has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Meilleure Health International Industry Group used its assets more efficiently than the HK Trade Distributors industry average last year based on Return on Assets.
  • Meilleure Health International Industry Group has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Meilleure Health International Industry Group's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Trade Distributors industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Meilleure Health International Industry Group has a total score of 3/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

2327 Health

 How is Meilleure Health International Industry Group's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Meilleure Health International Industry Group's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Meilleure Health International Industry Group is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Meilleure Health International Industry Group's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Meilleure Health International Industry Group's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 2.5x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Meilleure Health International Industry Group Company Filings, last reported 6 months ago.

SEHK:2327 Past Debt and Equity Data
Date (Data in HKD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 821.63 220.39 162.13
2018-09-30 821.63 220.39 162.13
2018-06-30 762.83 211.30 63.80
2018-03-31 762.83 211.30 63.80
2017-12-31 686.46 171.38 51.84
2017-09-30 686.46 171.38 51.84
2017-06-30 621.64 126.85 46.86
2017-03-31 621.64 126.85 46.86
2016-12-31 562.16 50.16 57.12
2015-12-31 314.92 0.00 197.41
2015-09-30 308.24 0.00 236.45
2015-06-30 308.24 0.00 236.45
2015-03-31 97.24 100.00 52.29
2014-12-31 97.24 100.00 52.29
2014-09-30 98.83 99.84 46.58
2014-06-30 98.83 99.84 46.58
2014-03-31 95.21 99.99 45.10
2013-12-31 95.21 99.99 45.10
2013-09-30 99.29 89.00 56.42
2013-06-30 99.29 89.00 56.42
2013-03-31 615.94 179.01 94.73
2012-12-31 615.94 179.01 94.73
2012-09-30 617.68 240.57 215.08
  • Meilleure Health International Industry Group's level of debt (26.8%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (105% vs 26.8% today).
  • Debt is not well covered by operating cash flow (8.1%, less than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 4.9x coverage).
X
Financial health checks
We assess Meilleure Health International Industry Group's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Meilleure Health International Industry Group has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

2327 Dividends

 What is Meilleure Health International Industry Group's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Meilleure Health International Industry Group dividends.
If you bought HK$2,000 of Meilleure Health International Industry Group shares you are expected to receive HK$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Meilleure Health International Industry Group's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Meilleure Health International Industry Group's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
SEHK:2327 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
Hong Kong Trade Distributors Industry Average Dividend Yield Market Cap Weighted Average of 12 Stocks 4.7%
Hong Kong Market Average Dividend Yield Market Cap Weighted Average of 978 Stocks 3.6%
Hong Kong Minimum Threshold Dividend Yield 10th Percentile 1.2%
Hong Kong Bottom 25% Dividend Yield 25th Percentile 2.1%
Hong Kong Top 25% Dividend Yield 75th Percentile 5.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

SEHK:2327 Future Dividends Estimate Data
Date (Data in HK$) Dividend per Share (annual) Avg. No. Analysts
2021-12-31
2020-12-31
2019-12-31
SEHK:2327 Past Annualized Dividends Data
Date (Data in HK$) Dividend per share (annual) Avg. Yield (%)
2019-04-18 0.000 0.000
2019-04-01 0.000 0.000
2018-09-20 0.000 0.000
2018-08-30 0.000 0.000
2018-04-27 0.006 1.459
2018-03-28 0.006 1.384
2017-09-28 0.006 1.671
2017-08-29 0.006 1.688
2013-12-12 0.000 0.000
2013-11-25 0.000 0.000
2013-06-19 0.000 0.000
2013-06-13 0.000 0.000
2012-06-04 0.021 5.343
2012-05-24 0.021 6.551
2011-07-12 0.060 17.164
2011-06-27 0.060 13.072
2010-07-26 0.013 2.656
2010-07-16 0.013 2.659
2009-06-22 0.010 3.114
2008-07-25 0.010 6.472

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Meilleure Health International Industry Group has not reported any payouts.
  • Unable to verify if Meilleure Health International Industry Group's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Meilleure Health International Industry Group's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Meilleure Health International Industry Group has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Meilleure Health International Industry Group's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Meilleure Health International Industry Group afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Meilleure Health International Industry Group has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

2327 Management

 What is the CEO of Meilleure Health International Industry Group's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Wen Chuan Zhou
COMPENSATION HK$540,000
AGE 36
TENURE AS CEO 5.8 years
CEO Bio

Ms. Wen Chuan Zhou has been the Chief Executive Officer and Executive Director of U-Home Group Holdings Limited since September 23, 2013. Ms. Zhou has been Vice Chairman of U-Home Group Holdings Limited. She obtained a master degree in Business Administration from the Chinese University of Hong Kong in 2011 and a master degree in Food Science and a bachelor degree in Science in Food Nutrition and Health from the University of British Columbia in 2008 and 2007 respectively.

CEO Compensation
  • Wen Chuan's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Wen Chuan's remuneration is lower than average for companies of similar size in Hong Kong.
Management Team Tenure

Average tenure and age of the Meilleure Health International Industry Group management team in years:

5.8
Average Tenure
56
Average Age
  • The average tenure for the Meilleure Health International Industry Group management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Xuzhou Zhou

TITLE
Co-Chairmen of the Board
COMPENSATION
HK$500K
AGE
63

Wentao Zeng

TITLE
Co-Chairmen & Executive Director
COMPENSATION
HK$120K
AGE
56
TENURE
0.2 yrs

Wen Chuan Zhou

TITLE
Vice Chairman & CEO
COMPENSATION
HK$540K
AGE
36
TENURE
5.8 yrs

Man Fai Shek

TITLE
Financial Controller & Company Secretary
AGE
44

Man Chun Chu

TITLE
Human Resources Manager
AGE
59

Pu Chun Feng

TITLE
Chief of R&D Dept - Kunming Jida Pharmaceutical Company Ltd and Director of R&D Dept - Kunming Jida
AGE
47

Chen Bang Hua

TITLE
President of Jiwa Rintech Holdings Limited and Executive Director of Jiwa Rintech Holdings Limited
AGE
64

Chun Xia Liu

TITLE
Quality Director of KJP and Director of Yunnan Jiwa Pharm-Tech Co Ltd
AGE
57
TENURE
22.3 yrs

Dong Mei Luo

TITLE
Executive Assistant to Chairman and COO of Kunming Jida Pharmaceutical Company Ltd
AGE
50
Board of Directors Tenure

Average tenure and age of the Meilleure Health International Industry Group board of directors in years:

3.8
Average Tenure
57
Average Age
  • The tenure for the Meilleure Health International Industry Group board of directors is about average.
Board of Directors

Xuzhou Zhou

TITLE
Co-Chairmen of the Board
COMPENSATION
HK$500K
AGE
63
TENURE
0.2 yrs

Wentao Zeng

TITLE
Co-Chairmen & Executive Director
COMPENSATION
HK$120K
AGE
56

Wen Chuan Zhou

TITLE
Vice Chairman & CEO
COMPENSATION
HK$540K
AGE
36

Chen Bang Hua

TITLE
President of Jiwa Rintech Holdings Limited and Executive Director of Jiwa Rintech Holdings Limited
AGE
64

Chun Xia Liu

TITLE
Quality Director of KJP and Director of Yunnan Jiwa Pharm-Tech Co Ltd
AGE
57

Guanjiang Gao

TITLE
Independent Non-Executive Director
COMPENSATION
HK$120K
AGE
66
TENURE
5.9 yrs

Wilton Chau

TITLE
Independent Non-Executive Director
COMPENSATION
HK$120K
AGE
58
TENURE
5.9 yrs

Zhenhua Mao

TITLE
Non-Executive Director
COMPENSATION
HK$120K
AGE
55
TENURE
3.8 yrs

Peng Wu

TITLE
Independent Non-Executive Director
AGE
36
TENURE
0.2 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Meilleure Health International Industry Group individual insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (HK$) Value (HK$)
14. Jun 19 Buy Xuzhou Zhou Individual 14. Jun 19 14. Jun 19 8,772,000 HK$0.65 HK$5,742,995
12. Jun 19 Buy Xuzhou Zhou Individual 12. Jun 19 12. Jun 19 1,200,000 HK$0.66 HK$792,002
04. Jun 19 Buy Xuzhou Zhou Individual 04. Jun 19 04. Jun 19 6,600,000 HK$0.63 HK$4,129,609
20. May 19 Buy Xuzhou Zhou Individual 20. May 19 20. May 19 4,500,000 HK$0.74 HK$3,312,435
17. May 19 Buy Xuzhou Zhou Individual 17. May 19 17. May 19 3,000,000 HK$0.81 HK$2,430,003
27. Apr 19 Buy Wentao Zeng Individual 26. Apr 19 26. Apr 19 15,000,000 HK$0.91 HK$13,649,999
27. Apr 19 Buy Xuzhou Zhou Individual 26. Apr 19 26. Apr 19 43,002,000 HK$0.91 HK$39,131,818
11. Apr 19 Sell Eagle Best Limited Company 09. Apr 19 09. Apr 19 -2,292,000 HK$1.43 HK$-3,276,413
11. Apr 19 Sell Eagle Best Limited Company 10. Apr 19 10. Apr 19 -9,180,000 HK$1.48 HK$-13,565,277
10. Apr 19 Sell Eagle Best Limited Company 08. Apr 19 08. Apr 19 -3,390,000 HK$1.50 HK$-5,096,537
10. Apr 19 Sell Chi Wai Chau Individual 08. Apr 19 08. Apr 19 -90,000 HK$1.60 HK$-144,000
04. Apr 19 Sell Eagle Best Limited Company 02. Apr 19 02. Apr 19 -1,248,000 HK$1.17 HK$-1,463,900
19. Oct 18 Buy Xuzhou Zhou Individual 18. Oct 18 18. Oct 18 1,200,000 HK$0.42 HK$499,438
12. Oct 18 Buy Wen Chuan Zhou Individual 12. Oct 18 12. Oct 18 1,320,000 HK$0.40 HK$526,017
12. Oct 18 Buy Xuzhou Zhou Individual 12. Oct 18 12. Oct 18 126,000 HK$0.41 HK$51,030
11. Oct 18 Buy Wen Chuan Zhou Individual 11. Oct 18 11. Oct 18 1,200,000 HK$0.40 HK$479,999
26. Sep 18 Buy Xuzhou Zhou Individual 24. Sep 18 24. Sep 18 1,848,000 HK$0.41 HK$766,913
18. Sep 18 Buy Xuzhou Zhou Individual 18. Sep 18 18. Sep 18 2,460,000 HK$0.36 HK$875,998
20. Jul 18 Buy Xuzhou Zhou Individual 19. Jul 18 19. Jul 18 1,080,000 HK$0.43 HK$462,671
X
Management checks
We assess Meilleure Health International Industry Group's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Meilleure Health International Industry Group has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

2327 News

Simply Wall St News

Does Meilleure Health International Industry Group Limited's (HKG:2327) CEO Pay Compare Well With Peers?

See our latest analysis for Meilleure Health International Industry Group How Does Wen Chuan Zhou's Compensation Compare With Similar Sized Companies? … Our data indicates that Meilleure Health International Industry Group Limited is worth HK$2.8b, and total annual CEO compensation is HK$540k. … Meilleure Health International Industry Group Limited is currently paying its CEO below what is normal for companies of its size.

Simply Wall St -

Taking A Look At Meilleure Health International Industry Group Limited's (HKG:2327) ROE

Check out our latest analysis for Meilleure Health International Industry Group How Do I Calculate Return On Equity? … The formula for return on equity is: Return on Equity = Net Profit ÷ Shareholders' Equity Or for Meilleure Health International Industry Group: 9.9% = HK$81m ÷ HK$822m (Based on the trailing twelve months to December 2018.) Most know that net profit is the total earnings after all expenses, but the concept of shareholders' equity is a little more complicated. … Combining Meilleure Health International Industry Group's Debt And Its 9.9% Return On Equity Meilleure Health International Industry Group has a debt to equity ratio of 0.27, which is far from excessive.

Simply Wall St -

How Good Is Meilleure Health International Industry Group Limited (HKG:2327) At Creating Shareholder Value?

The formula for calculating the return on capital employed is: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) Or for Meilleure Health International Industry Group: 0.055 = HK$57m ÷ (HK$1.3b - HK$268m) (Based on the trailing twelve months to December 2018.) Therefore, Meilleure Health International Industry Group has an ROCE of 5.5%. … View our latest analysis for Meilleure Health International Industry Group Is Meilleure Health International Industry Group's ROCE Good? … How Meilleure Health International Industry Group's Current Liabilities Impact Its ROCE Liabilities, such as supplier bills and bank overdrafts, are referred to as current liabilities if they need to be paid within 12 months.

Simply Wall St -

Have Insiders Been Buying Meilleure Health International Industry Group Limited (HKG:2327) Shares This Year?

So before you buy or sell Meilleure Health International Industry Group Limited (HKG:2327), you may well want to know whether insiders have been buying or selling. … See our latest analysis for Meilleure Health International Industry Group. … The good news for Meilleure Health International Industry Group share holders is that insiders were buying at near the current price.

Simply Wall St -

Why Meilleure Health International Industry Group Limited's (HKG:2327) High P/E Ratio Isn't Necessarily A Bad Thing

We'll show how you can use Meilleure Health International Industry Group Limited's (HKG:2327) P/E ratio to inform your assessment of the investment opportunity. … Meilleure Health International Industry Group has a P/E ratio of 52.97, based on the last twelve months. … View our latest analysis for Meilleure Health International Industry Group?

Simply Wall St -

Interested In Meilleure Health International Industry Group Limited (HKG:2327)? Here's How It Performed Recently

Below, I will examine Meilleure Health International Industry Group Limited's (HKG:2327) track record on a high level, to give you some insight into how the company has been performing against its long term trend and its industry peers. … Check out our latest analysis for Meilleure Health International Industry Group? … Did 2327 perform better than its track record and industry.

Simply Wall St -

How Much Did Meilleure Health International Industry Group Limited's (HKG:2327) CEO Pocket Last Year?

Wen Zhou became the CEO of Meilleure Health International Industry Group Limited (HKG:2327) in 2013. … View our latest analysis for Meilleure Health International Industry Group? … At the time of writing our data says that Meilleure Health International Industry Group Limited has a market cap of HK$4.3b, and is paying total annual CEO compensation of HK$540k.

Simply Wall St -

Can You Imagine How Chuffed Meilleure Health International Industry Group's Shareholders Feel About Its 149% Share Price Gain?

For example, the Meilleure Health International Industry Group Limited (HKG:2327) share price has soared 149% in the last three years. … Check out our latest analysis for Meilleure Health International Industry Group. … Meilleure Health International Industry Group was able to grow its EPS at 429% per year over three years, sending the share price higher.

Simply Wall St -

Is Meilleure Health International Industry Group Limited (HKG:2327) Struggling With Its 2.4% Return On Capital Employed?

Specifically, we'll consider its Return On Capital Employed (ROCE), since that will give us an insight into how efficiently the business can generate profits from the capital it requires. … Understanding Return On Capital Employed (ROCE). … How Do You Calculate Return On Capital Employed

Simply Wall St -

What Meilleure Health International Industry Group Limited's (HKG:2327) ROE Can Tell Us

To keep the lesson grounded in practicality, we'll use ROE to better understand Meilleure Health International Industry Group Limited (HKG:2327). … Over the last twelve months Meilleure Health International Industry Group has recorded a ROE of 11%. … Check out our latest analysis for Meilleure Health International Industry Group?

Simply Wall St -

2327 Company Info

Description

Meilleure Health International Industry Group Limited, an investment holding company, primarily provides anti-aging health management services in Hong Kong and Mainland China. It operates through Trading of Health Care Products, Agency Service, Property Development, Property Investment and Leasing Business, and Health Care Related Business segments. The company offers health check and personalized precision health management solutions, as well as anti-aging treatment services through its clinics. It is also involved in the trading of health care products, and building and chemical materials; sale of medicines; leasing of building materials; provision of real estate agency services; and development of residential properties. The company was formerly known as U-Home Group Holdings Limited and changed its name to Meilleure Health International Industry Group Limited in March 2017. Meilleure Health International Industry Group Limited is headquartered in Admiralty, Hong Kong.

Details
Name: Meilleure Health International Industry Group Limited
2327
Exchange: SEHK
Founded:
HK$2,733,921,687
4,271,752,636
Website: http://www.meilleure.com.cn
Address: Meilleure Health International Industry Group Limited
Tower 1,
Unit 2906,
Admiralty,
Hong Kong
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
SEHK 2327 Ordinary Shares The Stock Exchange of Hong Kong Ltd. HK HKD 14. Oct 2003
Number of employees
Current staff
Staff numbers
86
Meilleure Health International Industry Group employees.
Industry
Trading Companies and Distributors
Capital Goods
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/07/18 12:45
End of day share price update: 2019/07/18 00:00
Last estimates confirmation: 2019/07/06
Last earnings filing: 2019/04/18
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.